Multi or Single-Kinase Inhibitors to Counteract Drug Resistance in Cancer: What is New?-Reference-Cited by-同舟云学术

Multi or Single-Kinase Inhibitors to Counteract Drug Resistance in Cancer: What is New?

Published:2023-02 Issue:7 Volume:30 Page:776-782
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Diana Patrizia¹,Pecoraro Camilla¹,Carbone Daniela¹,Cascioferro Stella Maria¹,Parrino Barbara¹

Affiliation:

1. Department of Biological Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123 Palermo, Italy

Abstract

Funder

PRIN2017

Italian Ministry of Education, University and Research

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference39 articles.

1. Cohen P.; The origins of protein phosphorylation. Nat Cell Biol 2002,4(5),E127-E130

2. Wijnen R.; Pecoraro C.; Carbone D.; Fiuji H.; Avan A.; Peters G.J.; Giovannetti E.; Diana P.; Cyclin dependent kinase-1 (CDK-1) inhibition as a novel therapeutic strategy against pancreatic ductal adenocarcinoma (PDAC). Cancers (Basel) 2021,13(17),4389

3. Pecoraro C.; Faggion B.; Balboni B.; Carbone D.; Peters G.J.; Diana P.; Assaraf Y.G.; Giovannetti E.; GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer. Drug Resist Updat 2021,58,100779

4. Manning G.; Whyte D.B.; Martinez R.; Hunter T.; Sudarsanam S.; The protein kinase complement of the human genome. Science 2002,298(5600),1912-1934

5. Yaish P.; Gazit A.; Gilon C.; Levitzki A.; Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science 1988,242(4880),933-935

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015–2023);Pharmaceutical Fronts;2024-09-03

2. Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model;Recent Patents on Anti-Cancer Drug Discovery;2024-08

3. Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase;European Journal of Medicinal Chemistry;2024-08

4. Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro;Pharmaceuticals;2024-03-07

5. Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma;Archiv der Pharmazie;2024-01-31